What's Going On With InMode Stock Today?

InMode Ltd INMD shares are trading lower Tuesday after the company reported better-than-expected results, but issued a weak earnings forecast. 

What Happened: InMode said fourth-quarter revenue increased 21% year-over-year to $133.57 million, which beat average analyst estimates of $129.14 million, according to Benzinga Pro. The company reported quarterly adjusted earnings of 78 cents per share, which beat estimates of 67 cents per share.

InMode noted that its proprietary surgical technology platforms engaged in minimally invasive and subdermal ablative treatments represented 83% of quarterly revenues.

"We are happy to report another record revenue year and continuously high profitable growth as we scale globally and reach a yearly revenue run rate nearing $500 million," said Moshe Mizrahy, chairman and CEO of InMode.

"We are proud to have successfully navigated through the worldwide supply chain challenges in 2022, therefore fulfilling customer orders on time."

InMode sees full-year revenue between $525 million and $530 million versus estimates of $522.72 million. The company expects full-year adjusted earnings to be in a range of $2.58 to $2.60 per share versus estimates of $2.64 per share.

The company will host a conference call to discuss these results Tuesday morning at 8:30 a.m. InMode provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the U.S.

See Also: US Stocks Poised To Open Higher Ahead Of Inflation Report: Tame Data Could Keep S&P 500 Firmly Supported Above 4,100, Says Analyst

INMD Price Action: InMode has a 52-week high of $48.21 and a 52-week low of $20.60.

The stock was down 1.47% at $33.50 at time of publication, according to Benzinga Pro.

Photo: Lorenzo Cafaro from Pixabay.